Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 4, 2013

Drug Name	Review Type	Class	Manufacturer
Epaned	New Drug Initial Review	Hypertension in Children	Silvergate
TOBI Podhaler	New Drug Initial Review	Aminoglycoside	Novartis
Zubsolv	New Drug Appeal	Narcotic Withdrawal Agent	Orexo US
Diclegis	New Drug Appeal	Antiemetic	Duchesnay
Tivicay	New Drug Appeal	HIV antiretroviral	ViiV Healthcare
Quillivant XR	New Drug Appeal	Stimulants/ADHD	Pfizer

Footer